Jacqueline Diaz Albert InspectorProfile

This FDA InspectorProfile is a report of relevant audit-related information on Jacqueline Diaz Albert, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Biologics.

Product Description

This InspectorProfile report is updated through Mar 2022 and lists Jacqueline Diaz Albert's inspections in 14 countries: Germany, Belgium, Switzerland, France, United States, Austria, United Kingdom, Netherlands, Sweden, Italy, Spain, Canada, Ireland, and Denmark.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Jacqueline Diaz Albert's inspection information so that you can mitigate investigator-related risks.

Example Report

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Jacqueline Diaz Albert.

Product details

• Jacqueline Diaz Albert's metrics:
  • 483 issue rate, total inspections, total 483s
  • Most common citations (based on CFR), CFR description, and citation frequency
  • Total inspections, total 483s
  • Longest / shortest inspection in duration - all time, last year
  • Total warning letters
• Inspection details for each inspection (since 2000) Jacqueline Diaz Albert has conducted including:
  • Company, site inspected, duration of inspection
  • Co-inspectors Brentley Collins, Scott Norris, Marla Cassidy, Kimberly Schultz, Jason Abel, year of last co-inspection, number of co-inspections
  • If a 483 issued, and whether or not it resulted in a warning letter.

Note: The EIR and 483 documents are sold separately.